Insights

Funding momentum Epivara has actively secured SBIR grants from NSF and USDA totaling over $600k across multiple years, indicating strong validation of its non-surgical sterilization technology and potential for scalable R&D partnerships.

Public financing history A track record of competitive grant awards demonstrates credible government backing and potential for continued funding collaboration, creating opportunities to align sales efforts with grant-backed milestones or pilot programs.

humane solution The iSpay/iNeuter platform positions Epivara as a humane, cost-effective alternative to traditional surgeries, appealing to shelters, rescue organizations, and livestock producers seeking lower-cost fertility control and reduced animal handling risk.

Market fit With a focus on shelters, farms, and production animals, Epivara operates in a sector where large animal health suppliers and technology providers often partner for distribution, enabling cross-sell opportunities with veterinary consumables, data tools, or service packages.

Growth signals Revenue is in the low-to-mid single digits with a small team; this indicates a potential appetite for strategic partnerships, channel partnerships, or joint ventures to accelerate commercialization and scale field adoption of the technology.

Epivara Tech Stack

Epivara uses 8 technology products and services including Usercentrics, Google Cloud CDN, Open Graph, and more. Explore Epivara's tech stack below.

  • Usercentrics
    Consent Management
  • Google Cloud CDN
    Content Delivery Network
  • Open Graph
    Content Management System
  • Wix eCommerce
    E-commerce
  • Microsoft Excel
    Editors
  • Sentry
    Issue Trackers
  • HSTS
    Security
  • reCAPTCHA
    Security

Media & News

Epivara's Email Address Formats

Epivara uses at least 1 format(s):
Epivara Email FormatsExamplePercentage
First@epivara.comJohn@epivara.com
100%

Frequently Asked Questions

What is Epivara's official website and social media links?

Minus sign iconPlus sign icon
Epivara's official website is epivara.com and has social profiles on LinkedInCrunchbase.

How much revenue does Epivara generate?

Minus sign iconPlus sign icon
As of July 2026, Epivara's annual revenue is estimated to be $1M - $10M.

What is Epivara's NAICS code?

Minus sign iconPlus sign icon
Epivara's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Epivara have currently?

Minus sign iconPlus sign icon
As of July 2026, Epivara has approximately 12 employees across 1 continents, including North America. Key team members include Director Or Marketing And Brand: J. S.. Explore Epivara's employee directory with LeadIQ.

What industry does Epivara belong to?

Minus sign iconPlus sign icon
Epivara operates in the Pharmaceutical Manufacturing industry.

What technology does Epivara use?

Minus sign iconPlus sign icon
Epivara's tech stack includes UsercentricsGoogle Cloud CDNOpen GraphWix eCommerceMicrosoft ExcelSentryHSTSreCAPTCHA.

What is Epivara's email format?

Minus sign iconPlus sign icon
Epivara's email format typically follows the pattern of First@epivara.com. Find more Epivara email formats with LeadIQ.

How much funding has Epivara raised to date?

Minus sign iconPlus sign icon
As of July 2026, Epivara has raised $8.8M in funding. The last funding round occurred on Feb 18, 2025 for $4M.

When was Epivara founded?

Minus sign iconPlus sign icon
Epivara was founded in 2016.
Epivara logo

Epivara

Pharmaceutical ManufacturingIllinois, United States11-50 Employees

Epivara, a pharmaceutical manufacturing company based in Champaign, Illinois, focuses on humane, non-surgical methods for animal sterilization. Its flagship approach, iSpay and iNeuter, is designed to provide a simple, single-injection alternative to traditional spay/neuter procedures, with the aim of reducing animal discomfort and recovery time while offering a cost-effective solution for shelters, breeders, and farmers. The technology seeks to lower aggressive and sexual behaviors by suppressing hormone production, ultimately contributing to animal health, overpopulation control, and welfare in dogs, cats, and livestock.

Operating within the animal health and veterinary biotechnology sector, Epivara positions itself as a provider of innovative, non-invasive sterilization options that can be deployed across shelters, farms, and veterinary settings. The company has pursued early-stage research and development activities and has engaged with government-backed SBIR programs, reflecting its focus on advancing non-surgical sterilization methods for both female and male animals. Epivara has a presence in the U.S. market and emphasizes its rebranding from its former name, InSigna, while continuing to pursue its mission through scientific development and practical applications.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $8.8M

    Epivara has raised a total of $8.8M of funding over 5 rounds. Their latest funding round was raised on Feb 18, 2025 in the amount of $4Mas a series_unknown.

  • $1M - $10M

    Epivara's revenue is estimated to be in the range of $1M - $10M

Section iconFunding & Financials

  • $8.8M

    Epivara has raised a total of $8.8M of funding over 5 rounds. Their latest funding round was raised on Feb 18, 2025 in the amount of $4Mas a series_unknown.

  • $1M - $10M

    Epivara's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.